European health systems are only as strong as the science, talent, capital, and commercialization infrastructure behind them. This panel explores what it actually takes to build long-term health resilience in Europe, from supporting breakthrough research and scientists to scaling founder-led biotech and healthtech ventures.The discussion covers where European capital is flowing, why scientific innovation still struggles to leave the lab, and what founders need from investors beyond funding alone. A candid conversation about science, commercialization, and how the next generation of European healthcare innovation is being built.

Tiešsaistes seminārs par NATO STO praktiskās līdzdalības iespējām
5 views

Aktualitātes ekodizaina jomā
5 views

Deep Tech Frontier Stage: Day 1
63 views

Deep Frontier Stage: Opening keynote
37 views

Can Europe Build the Chips It Needs to Defend Itself?
30 views

The Chip War Is Real: How Semiconductors Decide Modern Warfare
30 views